DELTA 3 Showcases Long-Term Safety and Efficacy of Delgocitinib for Chronic Hand Eczema
New Study Reveals Risk Factors for Persistent Urticaria
ESK-001: A Conversation with Jörn Drappa, MD, PhD, of Alumis on Breakthrough Data and the Future of Psoriasis Treatment
Celebrating the "Derm Difference": Mona Gohara, MD, on the Impact of National Dermatologist Day